ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein -: A key role in glucose-mediated pancreatic β-cell survival

被引:85
作者
Costes, Safia
Broca, Christophe
Bertrand, Gyslaine
Lajoix, Anne-Dominique
Bataille, Dominique
Bockaert, Joel
Dalle, Stephane
机构
[1] Univ Montpellier 2, Equipe Avenir, INSERM U661,Univ Montpellier 1, Inst Genom Fonct,CNRS 5203, F-34094 Montpellier 5, France
[2] Fac Pharm Montpellier, CNRS, UMR 5160, F-34060 Montpellier, France
关键词
D O I
10.2337/db05-1618
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
cAMP-responsive element-binding protein (CREB) is required for beta-cell survival by regulating expression of crucial genes such as bcl-2 and IRS-2. Using MIN6 cells and isolated rat pancreatic islets, we investigated the signaling pathway that controls phosphorylation and protein level of CREB. We observed that 10 mmol/1 glucose-induced CREB phosphorylation was totally inhibited by the protein kinase A (PKA) inhibitor H89 (2 mu mol/1) and reduced by 50% with the extracellular signal-regulated kinase (ERK)1/2 inhibitor PD98059 (20 mu mol/1). This indicates that ERK1/2, reported to be located downstream of PKA, participates in the PKA-mediated CREB phosphorylation elicited by glucose. In ERK1/2-downregulated MIN6 cells by siRNA, glucose-stimulated CREB phosphorylation was highly reduced and CREB protein content was decreased by 60%. In MIN6 cells and islets cultured for 24-48 h in optimal glucose concentration (10 mmol/l), which promotes survival, blockade of ERK1/2 activity with PD98059 caused a significant decrease in CREB protein level, whereas CREB mRNA remained unaffected (measured by real-time quantitative PCR). This was associated with loss of bcl-2 mRNA and protein contents, caspase-3 activation, and emergence of ultrastructural apoptotic features detected by electron microscopy. Our results indicate that ERK1 and -2 control the phosphorylation and protein level of CREB and play a key role in glucose-mediated pancreatic beta-cell survival.
引用
收藏
页码:2220 / 2230
页数:11
相关论文
共 46 条
[1]  
BAUER GE, 1988, CELL TISSUE BIOL, P737
[2]   Mode of regulation of the extracellular signal-regulated kinases in the pancreatic β-cell line MIN6 and their implication in the regulation of insulin gene transcription [J].
Benes, C ;
Poitout, V ;
Marie, JC ;
Martin-Perez, J ;
Roisin, MP ;
Fagard, R .
BIOCHEMICAL JOURNAL, 1999, 340 :219-225
[3]   Rapid activation and nuclear translocation of mitogen-activated protein kinases in response to physiological concentration of glucose in the MIN6 pancreatic β cell line [J].
Benes, C ;
Roisin, MP ;
Van Tan, H ;
Creuzet, C ;
Miyazaki, J ;
Fagard, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) :15507-15513
[4]   Differential activation mechanisms of Erk-1/2 and p70S6K by glucose in pancreatic β-cells [J].
Briaud, I ;
Lingohr, MK ;
Dickson, LM ;
Wrede, CE ;
Rhodes, CJ .
DIABETES, 2003, 52 (04) :974-983
[5]   Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes -: Many differences, few similarities [J].
Cnop, M ;
Welsh, N ;
Jonas, JC ;
Jörns, A ;
Lenzen, S ;
Eizirik, DL .
DIABETES, 2005, 54 :S97-S107
[6]   Cooperative effects between protein kinase A and p44/p42 mitogen-activated protein kinase to promote cAMP-responsive element binding protein activation after β cell stimulation by glucose and its alteration due to glucotoxicity [J].
Costes, S ;
Longuet, C ;
Broca, C ;
Faruque, O ;
Hani, EH ;
Bataille, D ;
Dalle, S .
SIGNAL TRANSDUCTION PATHWAYS, CHROMATIN STRUCTURE, AND GENE EXPRESSION MECHANISMS AS THERAPEUTIC TARGETS, 2004, 1030 :230-242
[7]   Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway [J].
Dalle, S ;
Smith, P ;
Blache, P ;
Le-Nguyen, D ;
Le Brigand, L ;
Bergeron, F ;
Ashcroft, FM ;
Bataille, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10869-10876
[8]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[9]  
Docherty K, 1996, ELLENBERG RIFKINS DI, P29
[10]   Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets [J].
Farilla, L ;
Bulotta, A ;
Hirshberg, B ;
Calzi, SL ;
Khoury, N ;
Noushmehr, H ;
Bertolotto, C ;
Di Mario, U ;
Harlan, DM ;
Perfetti, R .
ENDOCRINOLOGY, 2003, 144 (12) :5149-5158